Breathing Muscle Training for Hospitalized Heart Failure Patients Waiting for Advanced Treatment
Tests breathing muscle exercises added to physical therapy in hospitalized adults with heart failure.
Key facts
- Who runs it
- NYU Langone Health
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Inspiratory Muscle Training in Hospitalized Patients With Heart Failure Awaiting Advanced Therapies
- Status
- Not yet recruiting
- People taking part
- 30 people, planned
- Started
- 10 Nov 2026
- Expected to end
- 10 Nov 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- POWERbreathe KH2
- Usual Care
- Record updated
- 16 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in hospital with severe heart failure (NYHA class III or IV) who are waiting for an LVAD or a heart transplant. It tests breathing muscle training added to usual physical therapy.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Heart failure, NYHA class III or IV, in hospital and awaiting an LVAD or heart transplant
Main reasons for not taking part
- Sent home from hospital to wait for an LVAD or heart transplant
- Expected hospital stay before surgery of less than 10 days
- Planned transplant of more than one organ
- Needs a breathing machine now
- Acute pneumothorax, acute rib fracture, acute stroke or acute delirium
The registry criteria, word for word
Show all 25 criteriaShow less
Who can take part
- 18 years old or older
- Able to provide consent and willing to participate in study procedures
- Currently hospitalized awaiting advanced therapies (LVAD or heart transplant)
- Diagnosed with NYHA class III or IV heart failure
- Able to follow instructions including the use of the Borg Dyspnea scale
- Physically able to independently hold and use the IMT
- Patients will undergo screening with or without active PT orders. To be enrolled in the study, patient must have an active physical therapy order. . If no active order exists, one will be requested from medical team following the screening and prior to enrollment
- Participants must meet institutional criteria for participation in physical therapy and mobility activities prior to enrollment and before each IMT session. Medical stability may include:; Mean arterial pressure (MAP) ≥ 60 mmHg and ≤ 120 mmHg; Resting heart rate between 40 and 140 beats per minute; No evidence of active myocardial ischemia or unstable angina; No uncontrolled atrial or ventricular arrhythmias; No escalating vasopressor or inotropic support at time of intervention; Oxygen saturation ≥ 94% on current oxygen support; Respiratory rate between 8 and 35 breaths per minute; Ability to follow simple commands and participate in study procedures; No acute neurologic, respiratory, or hemodynamic deterioration requiring immediate escalation of care; Clearance by the treating medical team to participate in rehabilitation activities
Who cannot take part
- Patients with an expectedpreoperative inpatient hospital stay of less than 10 days, based onreview of clinical status, treatment plan, and timing of expected surgery
- Abdominal surgery during present admission
- Patients discharged from the hospital to await advanced therapies (LVAD or heart transplant)
- Untreated hypertension, defined as systolic blood pressure consistently >140 mmHg or diastolic blood pressure consistently >90 mmHg in the absence of antihypertensive therapy
- Patients with planned multiple organ transplant (e.g. heart and kidney, heart and lung)
- A burst eardrum that has not fully healed, or any other condition of the eardrum
- Patients with worsening heart failure signs and symptoms after IMT
- Patients with acute pneumothorax
- Presence of acute rib fracture(s)
- Patients with acute cerebrovascular accident
- Acute delirium
- Perforated tympanic membrane
- Hemodynamic instability
- Patients currently requiring mechanical ventilatory support
- Patients with asthma who suffer from frequent severe exacerbations
- Patients with marked elevated left ventricular end-diastolic volume and pressure
- If you have suffered from or are likely to suffer from costochondritis
Where in United States
- NYU Langone HealthNew York, United StatesContact: Angela Stolfi, PT, DPTNot yet recruiting
About the trial
What the trial wants to find out
The primary objective of this study is to evaluate the feasibility and safety of inspiratory muscle training (IMT) when implemented as part of routine inpatient physical therapy care in patients undergoing evaluation for advanced heart therapies. The secondary aim is to determine if IMT improves 6-minute walk test (6MWT), dyspnea, Maximal Inspiratory Pressure (MIP) pre-operatively. Thirdly, to determine if IMT decreases ICU and hospital length of stay post-operatively.
The 2 groups in the trial
- Inspiratory Muscle Training (IMT) + Usual CareTreatment being tested
Participants will perform IMT 1 set of 30 breaths at 50% MIP, 5 days/week, in addition to usual care physical therapy.
Treatment: POWERbreathe KH2 and Usual Care
- Usual Care OnlyExisting treatment, for comparison
Participants in this arm will receive usual care physical therapy only.
Treatment: Usual Care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparing the Addition of Inspiratory Muscle Training (IMT) to Usual Care Physical Therapy in Hospitalized Patients With Heart Failure Awaiting Advanced Therapies: a Single-center Pilot Feasibility Study
- Plain-language title
- Breathing Muscle Training for Hospitalized Heart Failure Patients Waiting for Advanced TreatmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 16 October 2026